bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/22/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. SMCI
6. NOW
7. AMD
8. GM
9. IBM
10. EFX

Go back to bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
(NASDAQ: BIAF) Delayed: 0.71 --0 (-0%)
Previous Close $0.71    52 Week High $ 
Open $0.71    52 Week Low $ 
Day High $0.72    P/E N/A 
Day Low $0.70    EPS $ 
Volume 292,856       

(NASDAQ: BIAFW) Delayed: 0.10 --0 (-0%)
Previous Close $0.10    52 Week High $ 
Open $0.10    52 Week Low $ 
Day High $0.10    P/E N/A 
Day Low $0.10    EPS $ 
Volume 1,905,620